0001209191-12-054945.txt : 20121129
0001209191-12-054945.hdr.sgml : 20121129
20121129162455
ACCESSION NUMBER: 0001209191-12-054945
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20120509
FILED AS OF DATE: 20121129
DATE AS OF CHANGE: 20121129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MILLER LLOYD I III
CENTRAL INDEX KEY: 0000949119
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33560
FILM NUMBER: 121232094
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Capstone Therapeutics Corp.
CENTRAL INDEX KEY: 0000887151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 860585310
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1275 WEST WASHINGTON STREET
STREET 2: SUITE 101
CITY: TEMPE
STATE: AZ
ZIP: 85281
BUSINESS PHONE: 6022865520
MAIL ADDRESS:
STREET 1: 1275 WEST WASHINGTON STREET
STREET 2: SUITE 101
CITY: TEMPE
STATE: AZ
ZIP: 85281
FORMER COMPANY:
FORMER CONFORMED NAME: ORTHOLOGIC CORP
DATE OF NAME CHANGE: 19940211
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2012-05-09
0
0000887151
Capstone Therapeutics Corp.
CAPS
0000949119
MILLER LLOYD I III
222 LAKEVIEW AVENUE
SUITE 160-365
WEST PALM BEACH
FL
33401
0
0
1
0
Common Stock
2692085
I
By Trust A-4 - Lloyd I. Miller
Common Stock
641218
I
By Milgrat Q8
Common Stock
58967
D
Common Stock
724100
I
By Milfam NG LLC
The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any equity securities covered by this filing.
/s/ David J. Hoyt
Attorney-in-fact
2012-11-29
EX-24.3_445999
2
poa.txt
POA DOCUMENT
LIMITED POWER OF ATTORNEY
FOR SECTION 16 REPORTING OBLIGATIONS
Know all by these presents, that the undersigned hereby makes, constitutes and
appoints David J. Hoyt and Paul N. Silverstein, as the undersigned's true and
lawful attorneys-in-fact with full power and authority as hereinafter described
to:
(1) prepare, execute and acknowledge for and on behalf of the undersigned, in
the undersigned's capacity as an officer, director and/or a beneficial owner of
more than 10 percent of common stock of Capstone Therapeutics Corp. (the
"Company"), Forms 3, 4, and 5 (including any amendments thereto) in accordance
with Section 16(a) of the Securities Exchange Act of 1934 and the rules
thereunder (the "Exchange Act");
(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to prepare, complete and execute any such Form 3,
4, or 5, prepare, complete and execute any amendment or amendments thereto, and
timely deliver and file such form with the United States Securities and Exchange
Commission and any stock exchange or similar authority;
(3) seek or obtain, as the undersigned's representative and on the undersigned's
behalf, information regarding transactions in the Company's securities from any
third party, including brokers, employee benefit plan administrators and
trustees, and the undersigned hereby authorizes any such person to release any
such information to such attorney-in-fact and approves and ratifies any such
release of information; and
(4) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorneys-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Limited Power of Attorney shall be in such form and
shall contain such terms and conditions as the attorneys-in-fact may approve in
the attorneys-in-fact's discretion.
The undersigned hereby grants to the attorneys-in-fact full power and authority
to do and perform any and every act and thing whatsoever requisite, necessary,
or proper to be done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the undersigned might or could
do if personally present, with full power of substitution or revocation, hereby
ratifying and confirming all that the attorneys-in-fact, or the substitute or
substitutes of the attorneys-in-fact, shall lawfully do or cause to be done by
virtue of this power of attorney and the rights and powers herein granted. The
undersigned acknowledges that: (i) this power of attorney authorizes the
attorneys-in-fact to act in their discretion in preparing Forms 3, 4 and 5 on
information provided to the attorneys-in-fact without independent verification
of such information; (ii) the attorneys-in-fact, in serving in such capacity at
the request of the undersigned, is not assuming nor relieving, nor is the
Company assuming nor relieving, any of the undersigned's responsibilities to
comply with Section 16 of the Exchange Act; (iii) neither the Company nor the
foregoing attorneys-in-fact assume any liability for the undersigned's
responsibility to comply with the requirement of the Exchange Act or any
obligation or liability of the undersigned for profit disgorgement under Section
16(b) of the Exchange Act.
This Limited Power of Attorney shall remain in full force and effect until
revoked by the undersigned in a signed writing delivered to the foregoing
attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Limited Power of Attorney to
be executed as of this 26th day of November, 2012.
/s/ Lloyd I. Miller, III
Signature
Lloyd I. Miller, III
-------------------------
Print Name